| FRESENIUS MEDICAL CARE | 69.22 / +1.44% |
| Date/Time | 01/22 / 17:24 |
| Chg. / Chg.(%) | 0.98 / +1.44% |
| Bid | 67.28 / 2000 |
| Ask | 71.14 / 2000 |
| Open | 69.22 |
| Previous Close | 68.24 |
| High | 69.22 |
| Low | 69.22 |
| Volume [EUR] | 3,807.10 |
| Volume [Units] | 55 |
| Price fixings | 1 |
| ISIN | DE0005785802 |
| Security | FME |
| Exchange | Borsa Italiana |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| Lang & Schwa.. | 69.140 |  |
|
| Xetra | 69.22 | |
588,608 |
| Cboe Europe .. | 69.22 | |
246,162 |
| Turquoise | 69.16 | |
139,354 |
| London Inter.. | 69.28 | |
138,805 |
| TradeGate | 69.560 |  |
11,442 |
| Stuttgart | 69.300 | |
3,469 |
| gettex | 69.300 | |
2,032 |
| Frankfurt | 69.3200 | |
516 |
| München | 68.64 | |
425 |
| Cboe Europe .. | 68.91 | |
156 |
| Düsseldorf | 69.18 | |
100 |
| Hamburg | 68.84 | |
57 |
| Borsa Italia.. | 69.22 | |
55 |
| Hannover | 69.36 | |
51 |
| Berlin | 69.28 | |
33 |
| Cboe Europe .. | 69.36 | |
23 |
| Vienna Globa.. | 69.18 | |
0 |
| Nasdaq Other.. | 82.6200 | 1,000 | |
| Mexico | 1,938.55 | |
760 |
| EUREX | Options | ||
News
- ChemoCentryx and VFMCRP Provide Topline Results from ACCOLADE Trial of Avacopan in C3 Glomerulopathy Including Improved Estimated Glomerular Filtration Rate (eGFR)
12/21/2020 / 22:05 - GlobeNewswire - Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications
11/09/2020 / 07:00 - GlobeNewswire - ChemoCentryx and VFMCRP announce European Medicines Agency has accepted to review the Marketing Authorization Application for avacopan
11/03/2020 / 14:30 - GlobeNewswire - Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva™* to treat dialysis patients with pruritus
10/20/2020 / 07:00 - GlobeNewswire - ChemoCentryx and VFMCRP Announce Topline Data from Phase II LUMINA-1 Trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS)
05/18/2020 / 14:30 - GlobeNewswire
Real-time